M Fainaru

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

Mona Boaz, Shmuel Smetana, Talia Weinstein et al. · The Lancet · 2000 · 1K citations

Medicine, Nephrology, Dialysis +13

Parents as the exclusive agents of change in the treatment of childhood obesity

Moria Golan, Abraham Weizman, Alan Apter et al. · American Journal of Clinical Nutrition · 1998 · 460 citations

Medicine, Child Health, Pediatrics +14

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

S Eisenberg, Dov Gavish, Y Oschry et al. · Journal of Clinical Investigation · 1984 · 295 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +17

The removal of cholesterol from aortic smooth muscle cells in culture and landschutz ascites cells by fractions of human high-density apolipoprotein

Y. Stein, M.C. Glangeaud, M Fainaru et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1975 · 266 citations

Life Sciences, Cell Biology, Physiology +12

Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change

Moria Golan, M Fainaru, Abraham Weizman · International Journal of Obesity · 1998 · 239 citations

Public Health, Child Health, Health Behavior +15